The immunogenicity of a multiple antigenic peptide construct consisting of four copies of the synthetic 21-mer peptide DANFDSIRVDAVDNVDADLLQ was measured. The composition of this peptide was derived from a sequence in the N-terminal region of mutans streptococcal glucosyltransferases (GTFs) containing an aspartic acid implicated in catalysis. The peptide (CAT) construct was synthesized as a tetramer on a lysine backbone and subcutaneously injected into Sprague-Dawley rats for polyclonal antibody formation or intraperitoneally injected into BALB/c mice, and then spleen cell fused with Sp2/OAgl4 murine myeloma cells for monoclonal antibody formation. The resulting rat antisera and mouse monoclonal antibodies reacted with CAT and with native GTF isozymes from Streptococcus sobrinus and Streptococcus mutans (in enzyme-linked immunosorbent assay and Western blot [immunoblot] analyses). Functional inhibition of the water-insoluble glucan synthetic activity of S. sobrinus GTF-I was demonstrated with an immunoglobulin M anti-CAT monoclonal antibody (>80% inhibited) and with rat sera (approximately 17% inhibited). The monoclonal antibody preparation also modestly inhibited the water-soluble glucan synthetic activity of an S. mutans GTF mixture. These results suggest that the CAT peptide contains B-cell epitopes that are similar to those of intact mutans streptococcal GTFs and has the potential to elicit antibody that can inhibit GTF function. Thus, sequences within this peptide construct may have value for inclusion in a synthetic dental caries vaccine.
Dental caries in humans is associated primarily with the acidogenic and aciduric properties of the mutans streptococci (13) . The colonization and accumulation of these cariogenic oral streptococci on the tooth surface have been associated with the ability of mutans streptococci to synthesize extracellular glucan from sucrose (9) . Mutans streptococcal glucans are synthesized by glucosyltransferase enzymes (GTFs). The glucan-mediated accumulation of cariogenic mutans streptococci in dental plaque occurs through its interaction with cell-associated glucan-binding proteins (16) . Immunologic interference with (25, 27) or genetic alteration of (14) glucan synthetic mechanisms has been associated with a reduction in mutans streptococcal cariogenicity. Thus, the catalytic activity of GTFs can be viewed as a virulence trait of mutans streptococci.
We have begun to explore the potential for development of subunit dental caries vaccines based on epitopes derived from GTF. Epitopes associated with enzyme function would theoretically be primary targets, provided that the relevant sequence(s) was located in molecular areas that are accessible to antibody. The location of a catalytic domain in the N-terminal third of GTF has been suggested by Mooser and coworkers (19, 20) on the basis of identification of an aspartic acid in this region that was found to be radiolabelled with glucose after pepsin digestion of GTF that had been rapidly denatured after incubation with radiolabelled sucrose. The aim of the present study was to synthesize and test a peptide whose sequence was derived from the highly conserved region containing this putative catalytic site within the GTF molecule. The synthetic design included four copies of this peptide (CAT) on a lysine backbone (26) ; this design may potentially enhance immunogenicity while avoiding irrelevant responses that result from * Corresponding author. the use of carrier proteins. The characteristics of polyclonal antibodies (rat) and monoclonal antibodies (MAbs; mouse) to the CAT construct were then evaluated with respect to reactivity with Streptococcus sobrinus and Streptococcus mutans GTF and by functional inhibition of GTF activity.
MATERUILS AND METHODS
Antigens. (i) CAT synthetic peptide. We selected for synthesis a 21-mer peptide, DANFDSIRVDAVDNVDADLLQ, that had complete homology with the derived sequences of residues 444 to 464 of Streptococcus downei GTF-I (22) and residues 442 to 462 of S. mutans GTF-B (25) ( Table 1 ). The sequences of these two mutans streptococcal GTFs contain the aspartic acid (residues 453 [S. downei] and 451 [S. mutans GTF-B]) that has been suggested by Mooser et al. (19) to be the residue to which glucose is covalently bound in the active site. This sequence is highly conserved among mutans streptococcal GTFs (1, 6, 9, 10, 14) ( Table 1 ). The peptide was synthesized (Applied Diagnostics, Foster City, Calif.) by using the stepwise solid-phase method of Merrifield (17) on a core matrix of three lysines to yield a multiple antigenic peptide macromolecule with four identical 21-mer peptides per molecule, after the method of Tam (26) . Purity (>90%) was assessed by highperformance liquid chromatography, amino acid analysis, and molecular weight determination by mass spectrometry. This multiple antigenic peptide construct, referred to as CAT, was used for immunization and antibody analyses.
(ii) GTFs. GTFs from S. sobrinus 6715 and S. mutans SJ were obtained as described previously (24) . Briefly, after bacterial growth in glucose-containing defined media, enzymes were isolated by chromatography on Sephadex G-100 (Pharmacia Fine Chemicals), with 3 M guanidine HCl used as the eluting solvent. These GTF-rich pools were then subjected to fast protein liquid chromatography on Superose 6 (Pharma- (10, 29) 
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. . .507 100 GTF-D S. mutans (11, 12) 456 E...GV . . ..N. 476 81 CAT synthetic peptide DANFDSIRVDAVDNVDADLLQ a' , indicates the aspartic acid putatively associated with the catalytic activity of GTF by Mooser and coworkers (19, 20) . cia), with 6 M guanidine used for elution. The gel filtration step removes non-GTF and other glucan-binding proteins from GTF preparations of S. mutans and S. sobrinus, as evidenced by the fact that the protein bands observed after sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were all associated with enzymatic activity after incubation of duplicate gels in sucrose. The S. mutans GTF preparation taken to this level of enrichment synthesized more than 95% of the water-soluble glucan by both tube and filter assays (27) and thus was analogous to the gtJD gene product of S. mutans GS5 (12, 13) . This preparation was designated GTFSm and used for injection and enzyme-linked immunosorbent assay (ELISA).
S. sobrinus GTF preparations obtained after gel filtration on Superose 6 contained a mixture of GTF-I (water-insoluble glucan product), GTF-Sd (primer-dependent water-soluble glucan product), and GTF-Si (primer-independent water-soluble glucan product) (15, 16) . This preparation was designated GTFSS and used for injection and ELISA.
S. sobrinus GTF-I and GTF-Sd, used for measuring enzyme inhibition by rat antisera, were obtained by anion-exchange chromatography of the Superose 6 pool on MONO-Q (Pharmacia) as described previously (24, 28) . Virtually all of the glucan product of GTF-I synthesis was water insoluble when tested by either tube or filter assays (conditions reported in reference 24). Glucan synthesis by GTF-I was enhanced threefold in the presence of dextran T10 primer (Pharmacia). The quantitatively predominant GTF-Sd (16) synthesized a watersoluble product from sucrose in tube assays, which was enhanced sixfold in the presence of dextran primer. In filter assays, depending on the enzyme-substrate concentration, 8 to 30% of the glucan product of GTF-Sd synthesis was retained by the filter. Thus, for the purposes of the inhibition assay (see Tables 3 and 4) , the enzyme activities of GTF-Sd were described empirically as water soluble (not retained by the filter) and water insoluble (retained by the filter).
Immunization. Sprague-Dawley strain CD 65-day-old male rats (Charles River Laboratories) were used for injection. Rats were injected subcutaneously in the flanks and back with (i) 50 jig of the CAT construct (n = 3), (ii) 25 ELISA. Blood was taken from the retroorbital sinus of each rat. Serum, obtained from the coagulated specimen after centrifugation, was stored frozen at -20°C until use. Rat sera and mouse MAb reagents were tested for antibody activity by a previously described biotin-avidin, alkaline phosphatase ELISA method (25) . Polystyrene microtiter plates (Flow Laboratories, McLean, Va.) were coated with either 1 ,ug of poly-DL-alanine-poly-L-lysine (approximate molecular mass, 153 kDa; Sigma Chemical Co., St. Louis, Mo.) per ml, 0.5 p,g of the CAT peptide per ml, 0.5 ,ug of S. sobrinus 6715 GTFsE (Superose 6 pool containing GTF-I, GTF-Sd, and GTF-Si), or S. mutans SJ GTFsm (Superose 6 pool containing GTF-S activity) (24 (approximately 100,000 cpm) were added in 0.2 ml of PBSA in the presence of 37 pLg of dextran T10 (Pharmacia). Incubation proceeded for 18 h at 37°C, after which water-insoluble glucan was collected on Whatman GF/F glass fiber filters, the filters were washed with PBSA, and radioactivity was determined as described previously (28 (polyclonal rat anti-GTEss).
b The geometric mean reciprocol endpoint dilution of triplicate assays is given for each MAb or set of polyclonal rat sera (n = 2 to 3) after subtraction of corresponding preimmune or irrelevant MAb absorbances. The endpoint of the assay was taken as the dilution of the subtracted immune absorbance that was at least three standard deviations above that of the reagent background.
c Superose 6 pool of S. sobfinus GTE containing GTF-I, GTF-Sd, and GTF-Si (GTFsE).
d Superose 6 pool of S. mutans GTF.
GTF-I activity. CAT peptide, in a thousandfold range of concentrations, was then preincubated with immune and control reagents for 0.5 h at 37°C. After incubation of peptide, the assay for inhibition was conducted as described above.
RESULTS
Immunogenicity of the CAT synthetic peptide. (i) ELISA. IgG antibody to the CAT construct appeared in all rats after two subcutaneous injections of CAT (geometric mean = 2.0 x 105) ( Table 2 ) and continued to rise thereafter (not shown). GTF from S. sobrinus (GTFSS) elicited a serum IgG antibody response reactive with the homologous antigen at reciprocal dilutions greater than 105 and at dilutions greater than 104 with S. mutans GTF ( Table 2) . Sera from rats injected with CAT also reacted with both intact S. sobrinus and S. mutans GTF antigens, albeit at much lower dilutions than the anti-GTF sera, suggesting that a common epitope may exist on CAT and intact GTF.
Mouse MAbs to the CAT construct or to GTF-containing preparations were also tested for activity to these antigens in an ELISA (Table 2) . Of these MAbs, only the IgM anti-CAT MAb (IgM MAbCAT) showed a significant reaction with the CAT peptide. Each MAb preparation reacted with both S. sobrinus and S. mutans GTFs. The reactivity of the anti-CAT clone (ISM MAbCAT) with GTF at reciprocal dilutions greater than 10 confirmed that common epitopes exist on CAT and native GTF.
(ii) Western blot (immunoblot) analysis of rat polyclonal sera. The specific reactivity of IgG antibody in the sera of rats injected with CAT with S. sobrinus GTF-I was also demonstrated in Western blot analyses (Fig. 1) 14C-total glucan in the absence of inhibitor, approximately three-fourths of which was associated with water-insoluble glucan. Percentage inhibition was expressed relative to the mean counts per minute incorporated into water-insoluble or water-soluble glucan synthesized by GTF after preincubation with eight shaminjected rat serum samples as follows: mean ± standard deviation of [1 -(mean replicate cpm of an individual rat anti-CAT or anti-GTF serum sample/mean cpm of the eight sham-injected rat serum samples)] x 100.
c Expression of significance is based on a comparison of counts per minute of GTF preincubated with immune sera with counts per minute of GTF preincubated with sham sera by using one-way analysis of variance and the TukeyKramer multiple comparisons test. Tables 4 and  5 . The anti-CAT IgM MAb significantly inhibited the formation of filter-retained glucan by both S. sobrinus GTF-I and GTF-Sd. GTF-I activity was inhibited by the anti-CAT IgM MAb in a dose-dependent manner similar to that of a rat antiserum to S. sobnnus GTF (Fig. 2A) . MAb-based inhibition could be detected at concentrations of less than 50 ng per assay. Modest inhibition of water-soluble glucan synthesis by S.
sobrinus GTF-Sd and S. mutans GTF was also observed (Tables 4 and 5 ).
The control (TEPC 183) and anti-CAT IgM MAbs were reduced, alkylated, and retested in the GTF-I inhibition assay at concentrations of 13 ,ug/ml. The anti-CAT IgM monomers, obtained after gel filtration on Superose 6, inhibited the formation of 16% of the filter-retained glucan activity by S. sobrinus GTF-I, compared with essentially no inhibition by the (Fig. 2A) , the presence of monomer-based inhibition indicated that the IgM-mediated effects were not simply a function of the pentameric configuration and size.
IgM MAbGTF and IgG MAbGTF reactive with epitopes on intact GTF also inhibited the formation of filter-retained glucan by both S. sobrinus GTF-I and GTF-Sd activity (Tables  4 and 5 ). However, these IgG MAbs showed little or no inhibition of water-soluble glucan formation by S. sobrinus GTF-Sd or S. mutans GTF.
The specificity of the reaction of the immune sera and MAbs was further tested by preincubating the rat antiserum to GTFSs and the IgM and IgG MAb reagents with increasing concentrations of the CAT construct (Fig. 2B ). This pretreatment removed detectable GTF-inhibitory activity from the IgM anti-CAT MAb. No significant reduction in S. sobrinus GTF-I inhibition was observed by pretreatment of a rat antiserum to GTFSS with the CAT construct at concentrations as high as 1 mg/ml.
DISCUSSION
Molecular targets for potential immunological interference with GTF activity should be conformationally accessible to permit binding to antibody. The sequence DANFDSIRV-DAVDNVDADLLQ, selected for construct preparation and for immunization in this study, apparently shares an accessible epitope(s) with native GTF since antisera from rats injected with CAT, and MAb derived from similarly immunized mice, showed a substantial reaction with S. sobrinus GTF ( Fig. 1 ; Table 2 ).
Another consideration in the selection of sequences for a potential subunit vaccine to achieve the broadest protective effect would be that target epitopes are shared on GTFs from all mutans streptococcal species that infect humans. Much of the N-terminal sequence of mutans streptococcal GTF is highly conserved (1, 6, 7, 9, 11, 25) . In fact, the sequence reported in Table 1 differs by no more than two residues from the sequences of GTF-Is from mutans streptococci or Streptococcus salivarius. Thus, it could be expected that if the CAT peptide sequence includes an epitope(s) that is also sequentially defined on GTF, then a similar epitope(s) could be expected to be found on the GTF-I sequence of several species. Support for this hypothesis is seen in the reactions of both the rat polyclonal antibodies and mouse MAbs to CAT with S. sobrinus and S. mutans GTF ( Fig. 1; Table 2 ).
Although antibody binding to functionally important domains may not be necessary theoretically to achieve immunological protection, binding to catalytic domains should result in a loss of enzyme activity. The sequence DANFDSIRVDAVD NVDADLLQ contains an aspartic acid that has been implicated in an early catalytic step of glucan synthesis (19, 20) . Rat serum antibody (Table 3 ) and mouse IgM MAb (Tables 4 and  5 ) to the CAT construct both significantly inhibited the ability of S. sobrinus GTF to synthesize glucan. The mouse IgM anti-CAT MAb (IgM MAbCAT) was shown to inhibit GTF-I activity at concentrations as low as 50 ng per assay (Fig. 2) 
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IgMMAb. The water-insoluble glucan product of S. sobrinus GTF-Sd, whose activity is also dependent on the presence of dextran primer, was also inhibited by the MAb. The multiple specificities in polyclonal rat antibody to S. sobrinus GTEss gave the broadest range of inhibition, although the synthesis of water-soluble glucan by GTF-Sd was least affected (data not shown).
We have recently shown that antibody to a repeated sequence in the C-terminal third of GTF (GLU) could also inhibit GTF activity (24) . This sequence has been associated with glucan-binding properties of GTF (21, 22) . The pattern of GTF inhibition by antibody to GLU differed from that by antibody to CAT. Only the formation of water-insoluble glucan by S. sobrinus GTF-Sd was inhibited by rat anti-GLU antibody under the conditions of the assay. In contrast, the formation of water-insoluble glucan by both S. sobrinus GTF-I and GTF-Sd were the principal activities inhibited by the mouse IgM MAb to CAT. Rat antisera to CAT modestly inhibited the formation of water-soluble and water-insoluble glucan from S. sobrinus GTF mixtures. The mouse IgM MAbCAT also inhibited S. mutans GTF, although the level of inhibition was low. This interspecies inhibition pattern by the anti-CAT antibody may be due to the fact that the sequences corresponding to the CAT peptide are more highly conserved than those sequences corresponding to the GLU peptide. However, Chia et al. (2) found that MAb directed to a 19-mer sequence in the Nterminal third of S. mutans GTF inhibited the GTF-C but not the GTF-D isozyme, despite sequence identity in the respective regions of these two enzymes. These observations suggest that sequence homology is only one of several structural attributes that dictate epitopic structure among mutans streptococcal GTFs. Cope and Mooser (4) have reported that rabbit IgG antibody to two 22-mer peptides reacted only weakly with native GTF and did not inhibit S. sobrinus GTF-I or GTF-S, although their primary sequences were nearly identical to that of CAT. They suggested that these 22-mer peptides may not lie on the surface of GTF, thus limiting access of potentially inhibitory antibody to the eliciting peptide. Although this may be the case, these authors (4) used a monovalent peptide, unbound to carrier, for immunization, which may have limited the immunogenicity of the peptide. In the present study, the CAT peptide was synthesized as a quatravalent construct on a lysine backbone. The construct used in our studies resulted in the formation of rat antibody that reacted with native S. sobrinus and S. mutans GTF in an ELISA, and some of the more-hightitered sera significantly inhibited S. sobrinus GTF activity. The peptide configurations adopted by the monovalent (4) and quatravalent multiple antigenic peptide constructs, and the epitopes created by these configurations, are likely to differ in solution and give rise to antibody that differs in amount, specificity, and/or affinity. The genetic backgrounds of rats, mice, and rabbits may also contribute to variations in immune response parameters that lead to the formation of antibody.
Thus, antibody to epitopes present in the N-terminal (CAT) and C-terminal (GLU) regions of GTF apparently can interfere with enzyme function. In addition, Dertzbaugh and Macrina (5) have demonstrated inhibition of GTF activity with antibody to a chimeric peptide that included a sequence closer to the N terminus (residues 342 to 356) than the CAT sequence (residues 487 to 507) in S. mutans GTF-C (12, 29) . Also, Chia and coworkers (3) have synthesized a 19-mer peptide, homologous to a sequence nearly adjacent to the CAT region, that contained an epitope able to remove some of the GTF-inhibitory activity of polyclonal antibodies directed to S. mutans GTF-B and GTF-C. These 
